1. Home
  2. HSDT vs IDAI Comparison

HSDT vs IDAI Comparison

Compare HSDT & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • IDAI
  • Stock Information
  • Founded
  • HSDT N/A
  • IDAI 2016
  • Country
  • HSDT United States
  • IDAI United States
  • Employees
  • HSDT N/A
  • IDAI N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • HSDT Health Care
  • IDAI Technology
  • Exchange
  • HSDT Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • HSDT 6.4M
  • IDAI 7.7M
  • IPO Year
  • HSDT N/A
  • IDAI N/A
  • Fundamental
  • Price
  • HSDT $22.75
  • IDAI $3.12
  • Analyst Decision
  • HSDT Hold
  • IDAI
  • Analyst Count
  • HSDT 1
  • IDAI 0
  • Target Price
  • HSDT N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • HSDT 1.2M
  • IDAI 38.1K
  • Earning Date
  • HSDT 11-11-2025
  • IDAI 11-14-2025
  • Dividend Yield
  • HSDT N/A
  • IDAI N/A
  • EPS Growth
  • HSDT N/A
  • IDAI N/A
  • EPS
  • HSDT N/A
  • IDAI N/A
  • Revenue
  • HSDT $295,000.00
  • IDAI $3,366,415.00
  • Revenue This Year
  • HSDT N/A
  • IDAI $25.13
  • Revenue Next Year
  • HSDT $75.13
  • IDAI $48.09
  • P/E Ratio
  • HSDT N/A
  • IDAI N/A
  • Revenue Growth
  • HSDT N/A
  • IDAI N/A
  • 52 Week Low
  • HSDT $5.37
  • IDAI $1.43
  • 52 Week High
  • HSDT $1,200.00
  • IDAI $18.75
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 86.15
  • IDAI 55.54
  • Support Level
  • HSDT $5.78
  • IDAI $2.94
  • Resistance Level
  • HSDT $24.49
  • IDAI $3.29
  • Average True Range (ATR)
  • HSDT 1.62
  • IDAI 0.22
  • MACD
  • HSDT 2.35
  • IDAI 0.01
  • Stochastic Oscillator
  • HSDT 90.70
  • IDAI 65.50

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

Share on Social Networks: